Michael Cobas Meyer

Michael Cobas Meyer, MD MBA, is the Vice President of Global Patient Safety for Diabetes, Cardiovascular, and Other Complications at Eli Lilly and Company, where they also serve as Senior Vice President for Neuroscience Pain Early and Late Phase Drug Development and LRL Covid-19 Therapies. They previously held several leadership roles at Eli Lilly, including oversight of pharmacovigilance and risk management activities. Earlier in their career, they completed a residency at Hannover Medical School and conducted significant research as a Post-Doctoral Medical Research Fellow. Additionally, Michael is pursuing an MHM in Medical Hospital Management and continues their medical education at Medizinische Hochschule Hannover.